New Research Shows How Financial Engineering Could Make Life-Saving Drugs More Available and Affordable (Dana-Farber/Brigham and Women’s Cancer Center/Massachusetts General Hospital Cancer Center)
At a time when breakthrough therapies for certain cancers, hepatitis C, and rare diseases remain out of reach for many patients due to their prohibitive cost, new research by Dana-Farber Cancer Institute and MIT Sloan School researchers offers a potential remedy: securitized consumer healthcare loans (HCLs).
Dana-Farber/Brigham and Women's Cancer Center/Massachusetts General Hospital Cancer Center is one of the 26 NCCN Member Institutions.
...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Health | Hepatitis | Hepatitis C | Hospitals | Rare Diseases | Women